- Senior Clinician, Clinical Genetics Branch
Dr. Alter received a B.A. from Radcliffe College and an M.D. from Johns Hopkins University School of Medicine. She did an internship and residency in Pediatrics at Johns Hopkins, and a fellowship in Pediatric Hematology/Oncology at Boston Children's Hospital, as well as a postdoctoral fellowship at the Massachusetts Institute of Technology. She is board certified in Pediatrics and in Pediatric Hematology/Oncology, and is a fellow of the American Academy of Pediatrics. Her previous faculty appointments include:
- Assistant and Associate Professor of Pediatrics at Harvard Medical School (1974-79)
- Professor of Medicine and of Pediatrics at Mount Sinai School of Medicine (1979-92)
- Professor of Pediatrics and of Obstetrics and Gynecology, and Chief of Pediatric Hematology/Oncology at the University of Texas Medical Branch (1992-1999)
In 1999, Dr. Alter returned to Johns Hopkins to obtain an M.P.H. and then joined the Clinical Genetics Branch of the NCI Division of Cancer Epidemiology and Genetics in September 2000. She has published more than 300 peer-reviewed articles, books and book chapters.
- (1994). BIOLOGY OF ERYTHROPOIESIS. Annals of the New York Academy of Sciences. 731, 36-47.
- (1981). PRENATAL-DIAGNOSIS OF HEMOGLOBINOPATHIES - A STATUS-REPORT. LANCET. 2(8256), 1152-1155.
- (1980). HEMOGLOBIN SWITCHING - CELLULAR-MODEL. SCIENCE. 207(4431), 647-649.
- (1968). SWEATING IN CONGENITAL HEART DISEASE. PEDIATRICS. 41(1P1), 123-&.
- (2020). Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia. Science Translational Medicine. 12(566),
- (2020). Expansion of germlineRPS20mutation phenotype to include Diamond-Blackfan anemia. HUMAN MUTATION.
- (2020). Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis (vol 182, pg 465, 2020). BREAST CANCER RESEARCH AND TREATMENT. 183(2), 491-491.
- (2020). Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. BREAST CANCER RESEARCH AND TREATMENT. 182(2), 465-476.